Search Results - "Shilyansky JS"

Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms.

Authors: Grozinsky‐Glasberg, Simona Hofland, Johannes Alband, Stephanie et al.

Source: Journal of Neuroendocrinology. Dec2025, Vol. 37 Issue 12, p1-14. 14p.

Expression profiles of FABP4 and FABP5 in breast cancer: clinical implications and perspectives.

Authors: Jiang X Xiong Y Yu J et al.

Source: Discover oncology [Discov Oncol] 2025 Mar 19; Vol. 16 (1), pp. 357. Date of Electronic Publication: 2025 Mar 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors.

Authors: Shilyansky JS Chan CJ Xiao S et al.

Source: Surgery [Surgery] 2025 Mar; Vol. 179, pp. 108943. Date of Electronic Publication: 2024 Dec 10.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0417347 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-7361 (Electronic) Linking ISSN: 00396060 NLM ISO Abbreviation: Surgery Subsets: MEDLINE

FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARγ/CPT1A signaling pathway.

Authors: Zhang T Zhu J Geng L et al.

Source: Discover oncology [Discov Oncol] 2026 May 25; Vol. 17 (1). Date of Electronic Publication: 2026 May 25.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

Insulinoma Unmasked By Tirzepatide: A Rare Case of Postprandial Hypoglycemia In a Nondiabetic Patient.

Authors: Polisky, Michael Kamel, Dina Ku, Jeong-hee

Source: JCEM Case Reports. Jan2026, Vol. 4 Issue 1, p1-3. 3p.

Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases.

Authors: Zeng, Juan Tang, Xinxin Qin, Dalian et al.

Source: Journal of Nanobiotechnology. 10/15/2025, Vol. 23 Issue 1, p1-61. 61p.

Potential treatment benefits of a GLP-1R antagonist in combination with immune checkpoint inhibitors in colorectal cancer.

Authors: Zhan, Zengqin Zhan, Chuncha Li, Lianqiao et al.

Source: Oncology Letters. Apr2026, Vol. 31 Issue 4, pN.PAG-N.PAG. 1p.

Impact of biliary fungal contamination on outcomes after pancreaticoduodenectomy for pancreatic cancer.

Authors: Chang J Xiao S Su Y et al.

Source: Frontiers in oncology [Front Oncol] 2026 Feb 27; Vol. 16, pp. 1776853. Date of Electronic Publication: 2026 Feb 27 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Anti-diabetic medications and cancer: links beyond glycemic and body weight control.

Authors: Cao M Lin C Cai X et al.

Source: Precision clinical medicine [Precis Clin Med] 2025 Nov 07; Vol. 8 (4), pp. pbaf028. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101739592 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-1571 (Electronic) Linking ISSN: 25161571 NLM ISO Abbreviation: Precis Clin Med Subsets: PubMed not MEDLINE

Immunometabolism in cancer: a systemic perspective.

Authors: Moretti H Cioccoloni G Perucha E

Source: Frontiers in immunology [Front Immunol] 2025 Oct 08; Vol. 16, pp. 1656776. Date of Electronic Publication: 2025 Oct 08 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway.

Authors: Wang C Wu Z Zhou J et al.

Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 Mar 07; Vol. 151 (3), pp. 103. Date of Electronic Publication: 2025 Mar 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE